Back to search

Sweden· SE-20090113000039

Exemestane Accord 25 mg Filmdragerad tablett

A exemestane product containing exemestane, registered in Sweden by Accord Healthcare B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC L02BG06

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedExemestane Accord 25 mg Filmdragerad …ATCL02BG06REGISTER NO.SE-20090113000039PACKS LISTED1CHECKEDOctober 1, 2026

Where it is registered

Exemestane is registered in 17 of 19 countries.

Countries holding a registration under ATC L02BG06 (exemestane), each read from that country’s own register.

  • This record: Sweden, from Swedish Medical Products Agency (Sweden)
  • 10 of them publish a price we can compare per daily dose

Exemestane · ATC L02BG06

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of exemestane costs, country by country.

Normalised to the WHO defined daily dose (25 mg), the median price runs from $1.43 in France to $3.32 in Switzerland — a ×2.3 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Exemestane · price per daily dose (25 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.32
  • IT Italy$2.46
  • FR France$1.43
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Exemestane
Manufacturer
Accord Healthcare B.V.
Country
Sweden (SE)
ATC code
L02BG06
ATC class
Exemestane
Defined daily dose
25 mg, O
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20090113000039

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

236 interactions on record for exemestane.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Exemestane · interactions on record

236 records

  • 1 severe
  • 83 moderate
  • 152 info

Most severe, free to view

  • ThalidomideL04AX02severe
  • TroglitazoneA10BG01moderate
  • SulfinpyrazonB01AC12moderate
  • FostamatinibB02BX09moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Exemestane in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All exemestane products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Aromasin, Exemestan Accord
  • Belgium · Aromasin, Exemestan Sandoz
  • Bulgaria · Аромазин, Екземегратис
  • Cyprus · Exedral
  • Czechia · Aromasin, Astexana
  • Germany · Aromasin, Exemestan 1 A Pharma
  • Denmark · Aromasin, Exemestan Accord
  • Estonia · Aromasin, Exemestane Accord
  • Spain · Aromasil, Exemestano Aurovitas
  • Finland · Aromasin, Exemestan Pfizer
  • France · Aromasine, Exemestane Accord
  • United Kingdom (Northern Ireland) · Aromasin, Exemestane
  • Greece · Aromaplex, Aromasin
  • Croatia · Aromasin, Eksemestan Jgl
  • Hungary · Aromasin, Exemestane Pharmacenter
  • Ireland · Aromasin, Exemestane Accord
  • Iceland · Aromasin, Exemestan Actavis
  • Italy · Aromasin, Axelta
  • Lithuania · Aromasin, Exemestane Accord
  • Luxembourg · Aromasin, Exemestan Ratiopharm
  • Latvia · Exemestane Accord, Exemestane Sanoswiss
  • Malta · Aromasin, Exedral 25
  • Netherlands · Aromasin, Exemestaan Accord
  • Norway · Aromasin, Exemestan Sandoz
  • Poland · Astexana, Glandex
  • Portugal · Aromasin, Exemestano Accord
  • Romania · Aromasin, Exemestan Accord
  • Slovenia · Aromasin
  • Slovakia · Aromasin, Astexana

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f2693aad-218d-4fbe-92e0-0c744ee3720d
GET /v1/drugs/f2693aad-218d-4fbe-92e0-0c744ee3720d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "PL",
    "SmPC"
  ],
  "se_npl_id": "20090113000039",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20090113000039",
  "product_doc_link": "https://docetp.mpa.se/LMF/Exemestane%20Accord%20film-coated%20tablet%20SmPC_09001bee807a2e55.pdf"
}

See everything about exemestane.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.